Does the brain lead the metabolic decline in aging? Lessons from animal models and human centenarians

Xiaohui Ma, Radhika Muzumdar, Ilan Gabriely, Gil Atzmon, Nir Barzilai

Research output: Contribution to journalArticle

Abstract

We hypothesize that age-related metabolic alterations originate in the brain (studies in rodents), and that the functional decline of the brain may be protected by a favorable metabolic profile (studies in human centenarians). The metabolic decline with aging is associated with a progressive increase in fat mass in mammals and caloric restriction enhances life span in rodents. Here we show that a diminished biological response to leptin is a feature of aging. Leptin is a fat derived peptide that decreases body weight, fat mass, improves insulin sensitivity and energy expenditure through its receptors in the hypothalamus. We examined the effects of exogenous leptin on several metabolic parameters as a function of aging in rats. A prolonged elevation in plasma leptin levels in aging rats failed to decrease food intake, total fat mass, and intra-abdominal fat. Furthermore, the effects of leptin on liver triglyceride content, on insulin action and insulin secretion were markedly decreased in these animals compared to young controls. Leptin's failure in this aging model suggests its role in age-associated body fat accumulation, fat distribution and insulin resistance. We propose that a central nervous system resistance to leptin is probably a primary event that leads to the metabolic syndrome of aging, especially when availability of calories is unrestricted. Families of centenarians often have extremely high levels of high-density lipoprotein (HDL), which may have neurological as well as cardiovascular protective effects during aging. Because HDL level declines with aging, we tested if centenarians with higher HDL levels have greater cognitive protection. HDL levels correlated significantly with mini-mental state score (MMSE) of the centenarian, and each decrease in HDL tertile was associated with significant decrease in MMSE. These data suggests that the appearance of cognitive dysfunction in centenarians is associated with a decline in HDL cholesterol. This underscores the protective effects of increased HDL cholesterol, and its role in longevity. Taken together, these data suggest a determinant role for brain in the metabolic decline of aging, and highlight the advantage of favorable metabolic profile on the protection of brain from age-related cognitive decline.

Original languageEnglish (US)
Pages (from-to)339-344
Number of pages6
JournalClinical Neuroscience Research
Volume2
Issue number5-6
DOIs
StatePublished - Jan 2003

Fingerprint

Leptin
Animal Models
HDL Lipoproteins
Brain
Fats
Metabolome
HDL Cholesterol
Insulin Resistance
Rodentia
Insulin
Caloric Restriction
Intra-Abdominal Fat
Energy Metabolism
Hypothalamus
Adipose Tissue
Mammals
Triglycerides
Central Nervous System
Eating
Body Weight

Keywords

  • Centarians
  • Cognitive function
  • HDL cholesterol
  • Leptin
  • Visceral fat

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Neurology
  • Neuropsychology and Physiological Psychology

Cite this

Does the brain lead the metabolic decline in aging? Lessons from animal models and human centenarians. / Ma, Xiaohui; Muzumdar, Radhika; Gabriely, Ilan; Atzmon, Gil; Barzilai, Nir.

In: Clinical Neuroscience Research, Vol. 2, No. 5-6, 01.2003, p. 339-344.

Research output: Contribution to journalArticle

Ma, Xiaohui ; Muzumdar, Radhika ; Gabriely, Ilan ; Atzmon, Gil ; Barzilai, Nir. / Does the brain lead the metabolic decline in aging? Lessons from animal models and human centenarians. In: Clinical Neuroscience Research. 2003 ; Vol. 2, No. 5-6. pp. 339-344.
@article{4fcbf225e4cc4f6d8847a83aabaea669,
title = "Does the brain lead the metabolic decline in aging? Lessons from animal models and human centenarians",
abstract = "We hypothesize that age-related metabolic alterations originate in the brain (studies in rodents), and that the functional decline of the brain may be protected by a favorable metabolic profile (studies in human centenarians). The metabolic decline with aging is associated with a progressive increase in fat mass in mammals and caloric restriction enhances life span in rodents. Here we show that a diminished biological response to leptin is a feature of aging. Leptin is a fat derived peptide that decreases body weight, fat mass, improves insulin sensitivity and energy expenditure through its receptors in the hypothalamus. We examined the effects of exogenous leptin on several metabolic parameters as a function of aging in rats. A prolonged elevation in plasma leptin levels in aging rats failed to decrease food intake, total fat mass, and intra-abdominal fat. Furthermore, the effects of leptin on liver triglyceride content, on insulin action and insulin secretion were markedly decreased in these animals compared to young controls. Leptin's failure in this aging model suggests its role in age-associated body fat accumulation, fat distribution and insulin resistance. We propose that a central nervous system resistance to leptin is probably a primary event that leads to the metabolic syndrome of aging, especially when availability of calories is unrestricted. Families of centenarians often have extremely high levels of high-density lipoprotein (HDL), which may have neurological as well as cardiovascular protective effects during aging. Because HDL level declines with aging, we tested if centenarians with higher HDL levels have greater cognitive protection. HDL levels correlated significantly with mini-mental state score (MMSE) of the centenarian, and each decrease in HDL tertile was associated with significant decrease in MMSE. These data suggests that the appearance of cognitive dysfunction in centenarians is associated with a decline in HDL cholesterol. This underscores the protective effects of increased HDL cholesterol, and its role in longevity. Taken together, these data suggest a determinant role for brain in the metabolic decline of aging, and highlight the advantage of favorable metabolic profile on the protection of brain from age-related cognitive decline.",
keywords = "Centarians, Cognitive function, HDL cholesterol, Leptin, Visceral fat",
author = "Xiaohui Ma and Radhika Muzumdar and Ilan Gabriely and Gil Atzmon and Nir Barzilai",
year = "2003",
month = "1",
doi = "10.1016/S1566-2772(03)00011-2",
language = "English (US)",
volume = "2",
pages = "339--344",
journal = "Clinical Neuroscience Research",
issn = "1566-2772",
publisher = "Elsevier BV",
number = "5-6",

}

TY - JOUR

T1 - Does the brain lead the metabolic decline in aging? Lessons from animal models and human centenarians

AU - Ma, Xiaohui

AU - Muzumdar, Radhika

AU - Gabriely, Ilan

AU - Atzmon, Gil

AU - Barzilai, Nir

PY - 2003/1

Y1 - 2003/1

N2 - We hypothesize that age-related metabolic alterations originate in the brain (studies in rodents), and that the functional decline of the brain may be protected by a favorable metabolic profile (studies in human centenarians). The metabolic decline with aging is associated with a progressive increase in fat mass in mammals and caloric restriction enhances life span in rodents. Here we show that a diminished biological response to leptin is a feature of aging. Leptin is a fat derived peptide that decreases body weight, fat mass, improves insulin sensitivity and energy expenditure through its receptors in the hypothalamus. We examined the effects of exogenous leptin on several metabolic parameters as a function of aging in rats. A prolonged elevation in plasma leptin levels in aging rats failed to decrease food intake, total fat mass, and intra-abdominal fat. Furthermore, the effects of leptin on liver triglyceride content, on insulin action and insulin secretion were markedly decreased in these animals compared to young controls. Leptin's failure in this aging model suggests its role in age-associated body fat accumulation, fat distribution and insulin resistance. We propose that a central nervous system resistance to leptin is probably a primary event that leads to the metabolic syndrome of aging, especially when availability of calories is unrestricted. Families of centenarians often have extremely high levels of high-density lipoprotein (HDL), which may have neurological as well as cardiovascular protective effects during aging. Because HDL level declines with aging, we tested if centenarians with higher HDL levels have greater cognitive protection. HDL levels correlated significantly with mini-mental state score (MMSE) of the centenarian, and each decrease in HDL tertile was associated with significant decrease in MMSE. These data suggests that the appearance of cognitive dysfunction in centenarians is associated with a decline in HDL cholesterol. This underscores the protective effects of increased HDL cholesterol, and its role in longevity. Taken together, these data suggest a determinant role for brain in the metabolic decline of aging, and highlight the advantage of favorable metabolic profile on the protection of brain from age-related cognitive decline.

AB - We hypothesize that age-related metabolic alterations originate in the brain (studies in rodents), and that the functional decline of the brain may be protected by a favorable metabolic profile (studies in human centenarians). The metabolic decline with aging is associated with a progressive increase in fat mass in mammals and caloric restriction enhances life span in rodents. Here we show that a diminished biological response to leptin is a feature of aging. Leptin is a fat derived peptide that decreases body weight, fat mass, improves insulin sensitivity and energy expenditure through its receptors in the hypothalamus. We examined the effects of exogenous leptin on several metabolic parameters as a function of aging in rats. A prolonged elevation in plasma leptin levels in aging rats failed to decrease food intake, total fat mass, and intra-abdominal fat. Furthermore, the effects of leptin on liver triglyceride content, on insulin action and insulin secretion were markedly decreased in these animals compared to young controls. Leptin's failure in this aging model suggests its role in age-associated body fat accumulation, fat distribution and insulin resistance. We propose that a central nervous system resistance to leptin is probably a primary event that leads to the metabolic syndrome of aging, especially when availability of calories is unrestricted. Families of centenarians often have extremely high levels of high-density lipoprotein (HDL), which may have neurological as well as cardiovascular protective effects during aging. Because HDL level declines with aging, we tested if centenarians with higher HDL levels have greater cognitive protection. HDL levels correlated significantly with mini-mental state score (MMSE) of the centenarian, and each decrease in HDL tertile was associated with significant decrease in MMSE. These data suggests that the appearance of cognitive dysfunction in centenarians is associated with a decline in HDL cholesterol. This underscores the protective effects of increased HDL cholesterol, and its role in longevity. Taken together, these data suggest a determinant role for brain in the metabolic decline of aging, and highlight the advantage of favorable metabolic profile on the protection of brain from age-related cognitive decline.

KW - Centarians

KW - Cognitive function

KW - HDL cholesterol

KW - Leptin

KW - Visceral fat

UR - http://www.scopus.com/inward/record.url?scp=23744433898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23744433898&partnerID=8YFLogxK

U2 - 10.1016/S1566-2772(03)00011-2

DO - 10.1016/S1566-2772(03)00011-2

M3 - Article

AN - SCOPUS:23744433898

VL - 2

SP - 339

EP - 344

JO - Clinical Neuroscience Research

JF - Clinical Neuroscience Research

SN - 1566-2772

IS - 5-6

ER -